ロード中...
Development of a High-Throughput Screen for Inhibitors of Epstein-Barr Virus EBNA1
Latent infection with Epstein-Barr Virus (EBV) is a carcinogenic cofactor in several lymphoid and epithelial cell malignancies. At present, there are no small molecule inhibitors that specifically target EBV latent infection or latency-associated oncoproteins. EBNA1 is an EBV-encoded sequence-specif...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3310380/ https://ncbi.nlm.nih.gov/pubmed/20930215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1087057110379154 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|